TMDX - TransMedics Group, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2019
12/30/2018
12/30/2017
12/30/2016
Total Revenue
23,604
23,604
13,017
7,685
6,209
Cost of Revenue
9,741
9,741
7,283
5,548
5,443
Gross Profit
13,863
13,863
5,734
2,137
766
Operating Expenses
Research Development
19,870
19,870
13,656
14,957
15,637
Selling General and Administrative
23,596
23,596
12,315
7,606
8,115
Total Operating Expenses
43,466
43,466
25,971
22,563
23,752
Operating Income or Loss
-29,603
-29,603
-20,237
-20,426
-22,986
Interest Expense
4,353
4,353
2,720
1,072
979
Total Other Income/Expenses Net
449
449
-758
707
-100
Income Before Tax
-33,507
-33,507
-23,715
-20,791
-24,065
Income Tax Expense
40
40
41
32
0
Income from Continuing Operations
-33,547
-33,547
-23,756
-20,823
-24,065
Net Income
-33,547
-33,547
-23,756
-20,823
-24,065
Net Income available to common shareholders
-33,547
-33,547
-23,211
-20,823
-24,065
Basic EPS
-
-
-1.60
-1.44
-1.66
Diluted EPS
-
-
-1.60
-1.44
-1.66
Basic Average Shares
-
-
14,478
14,478
14,478
Diluted Average Shares
-
-
14,478
14,478
14,478
EBITDA
-
-27,932
-20,226
-19,089
-22,660